Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price […]
Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) have received a consensus rating of “Moderate Buy” from the eight analysts that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month […]
Acrivon Therapeutics (NASDAQ:ACRV) Receives Outperform Rating from BMO Capital Markets themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
LADENBURG THALM/SH SH lowered shares of Acrivon Therapeutics (NASDAQ:ACRV – Free Report) from a buy rating to a neutral rating in a research report report published on Monday morning, Marketbeat Ratings reports. Other equities analysts also recently issued research reports about the company. HC Wainwright reaffirmed a buy rating and issued a $20.00 price objective […]
Piper Sandler Increases Acrivon Therapeutics (NASDAQ:ACRV) Price Target to $30 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.